132 related articles for article (PubMed ID: 24900265)
41. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ
Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924
[TBL] [Abstract][Full Text] [Related]
42. CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders.
Mamik MK; Ghorpade A
Curr Drug Targets; 2016; 17(1):111-21. PubMed ID: 26112047
[TBL] [Abstract][Full Text] [Related]
43. Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.
Ravindran A; Sawant KV; Sarmiento J; Navarro J; Rajarathnam K
J Biol Chem; 2013 Apr; 288(17):12244-52. PubMed ID: 23479735
[TBL] [Abstract][Full Text] [Related]
44. Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases.
Matityahu E; Feniger-Barish R; Meshel T; Zaslaver A; Ben-Baruch A
Eur J Immunol; 2002 Dec; 32(12):3525-35. PubMed ID: 12442335
[TBL] [Abstract][Full Text] [Related]
45. Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure.
Khanam A; Trehanpati N; Riese P; Rastogi A; Guzman CA; Sarin SK
Front Immunol; 2017; 8():464. PubMed ID: 28484461
[TBL] [Abstract][Full Text] [Related]
46. CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo.
Li F; Zhang X; Mizzi C; Gordon JR
Vet Immunol Immunopathol; 2002 Nov; 90(1-2):65-77. PubMed ID: 12406656
[TBL] [Abstract][Full Text] [Related]
47. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
Russo RC; Garcia CC; Teixeira MM; Amaral FA
Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
[TBL] [Abstract][Full Text] [Related]
48. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
Zaslaver A; Feniger-Barish R; Ben-Baruch A
J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
[TBL] [Abstract][Full Text] [Related]
50. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
51. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
[TBL] [Abstract][Full Text] [Related]
52. Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils.
Strandberg K; Blidberg K; Sahlander K; Palmberg L; Larsson K
Pulm Pharmacol Ther; 2010 Aug; 23(4):316-23. PubMed ID: 20307681
[TBL] [Abstract][Full Text] [Related]
53. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
[TBL] [Abstract][Full Text] [Related]
54. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.
Ha H; Debnath B; Neamati N
Theranostics; 2017; 7(6):1543-1588. PubMed ID: 28529637
[TBL] [Abstract][Full Text] [Related]
55. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4.
Sabroe I; Jones EC; Whyte MK; Dower SK
Immunology; 2005 May; 115(1):90-8. PubMed ID: 15819701
[TBL] [Abstract][Full Text] [Related]
56. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice.
Cunha TM; Barsante MM; Guerrero AT; Verri WA; Ferreira SH; Coelho FM; Bertini R; Di Giacinto C; Allegretti M; Cunha FQ; Teixeira MM
Br J Pharmacol; 2008 May; 154(2):460-70. PubMed ID: 18362895
[TBL] [Abstract][Full Text] [Related]
57. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
58. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
59. Molecular aspects, genomic arrangement and immune responsive mRNA expression profiles of two CXC chemokine receptor homologs (CXCR1 and CXCR2) from rock bream, Oplegnathus fasciatus.
Umasuthan N; Wan Q; Revathy KS; Whang I; Noh JK; Kim S; Park MA; Lee J
Fish Shellfish Immunol; 2014 Sep; 40(1):304-18. PubMed ID: 24945570
[TBL] [Abstract][Full Text] [Related]
60. Cloning and characterization of guinea pig CXCR1.
Takahashi M; Jeevan A; Sawant K; McMurray DN; Yoshimura T
Mol Immunol; 2007 Feb; 44(5):878-88. PubMed ID: 16712933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
